Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Side effects, dropouts from treatment and cost consequences

S A Montgomery1, S Kasper

  • 1Department of Pharmacology, Imperial College School of Medicine, London, UK.

International Clinical Psychopharmacology
|July 21, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intermittent At-Home Suctioning of Esophageal Content for Prevention of Recurrent Aspiration Pneumonia in 4 Dogs with Megaesophagus.

Journal of veterinary internal medicine·2016
Same author

Identification of candidate genes for chicken early- and late-feathering.

Poultry science·2016
Same author

First european meeting for diseases algorithms on the psychopharmacology of psychiatric.

International journal of psychiatry in clinical practice·2014
Same author

Editorial.

International journal of psychiatry in clinical practice·2014
Same author

Sertindole: safety and tolerability profile.

International journal of psychiatry in clinical practice·2014
Same author

Physical signs in psychiatry: a step towards evidence-based medicine.

International journal of psychiatry in clinical practice·2014

Estimating depression treatment costs requires considering direct, indirect, and intangible expenses. Choosing better-tolerated antidepressants, like selective serotonin reuptake inhibitors, can reduce overall costs by improving treatment compliance.

Area of Science:

  • Pharmacoeconomics
  • Psychiatry
  • Mental Health Treatment

Background:

  • Depression incurs significant direct (medication, care) and indirect (productivity loss, unemployment) costs.
  • Intangible costs to patients are substantial but difficult to quantify.
  • Depression's morbidity and mortality contribute heavily to its overall economic burden.

Purpose of the Study:

  • To analyze the pharmacoeconomic implications of depression treatment.
  • To evaluate how antidepressant choice impacts overall treatment costs.
  • To emphasize the role of treatment compliance in cost-effectiveness.

Main Methods:

  • Review of meta-analyses comparing antidepressant side effect profiles.
  • Pharmacoeconomic analysis considering treatment discontinuation rates.

Related Experiment Videos

  • Comparison of total costs associated with different antidepressant classes.

    • Main Results:

    • Selective serotonin reuptake inhibitors (SSRIs) have lower discontinuation rates due to side effects than tricyclic antidepressants (TCAs).
    • While TCAs may appear cheaper initially, higher discontinuation rates increase overall treatment costs.
    • Better-tolerated antidepressants can lead to more cost-effective depression management.

    Conclusions:

    • Treatment compliance is crucial for reducing the economic burden of depression.
    • Prioritizing well-tolerated antidepressants like SSRIs is essential for effective and cost-efficient depression care.
    • Pharmacoeconomic evaluations must account for treatment failures caused by side effects.